| 351. | | | Self-defense of human sarcoma cells against cytolytic lymphoid cells of their host
|
| 352. | | | Seroepidemiology of infection with Neospora caninum, Leptospira, and bovine herpesvirus type 1 in water buffaloes (Bubalus bubalis) in Veracruz, Mexico
|
| 353. | | | Seroepidemiology of Leptospira infection in backyard pigs in Durango State, Mexico
|
| 354. | | | Seroepidemiology of Toxoplasma Gondii Infection in People Applying for Medical Certificates
|
| 355. | | | Seroprevalence of Campylobacter-Specific Antibodies in two German Duck Farms - A Prospective Follow-Up Study
|
| 356. | | | Seroprevalence of Chlamydophila psittaci among employees of two German duck farms
|
| 357. | | | Sexually Transmitted Infections in Soldiers - A Cross-Sectional Assessment in German Paratroopers and Navy Soldiers and a Literature Review
|
| 358. | | | SHP2-independent tyrosine dephosphorylation of cortactin and vinculin during infection with Helicobacter pylori
|
| 359. | | | Small intestinal pro-inflammatory immune responses following Campylobacter jejuni infection of secondary abiotic IL-10-/- mice lacking nucleotide-oligomerization-domain-2
|
| 360. | | | So close and yet so far - molecular microbiology of Campylobacter fetus subspecies
|
| 361. | | | Spatial and temporal dynamics of the prevalence of resistance genes and gastrointestinal pathogens in stool samples of German deployment returnees
|
| 362. | | | Spectrum of viral infections in patients with cystic fibrosis
|
| 363. | | | Spinal cord pathology in chronic experimental Toxoplasma gondii infection
|
| 364. | | | Staphylococcus aureus: Antimicrobial resistance, quorum sensing, and antibiofilm approaches
|
| 365. | | | Stillbirth history and Toxoplasma gondii infection in women attending public health centers in a northern Mexican city
|
| 366. | | | Structural biology of Nipah virus G and F glycoproteins: Insights into therapeutic and vaccine development
|
| 367. | | | Surveillance of enteropathogenic bacteria, protozoa and helminths in travellers returning from the tropics
|
| 368. | | | Survey of extra-intestinal immune responses in asymptomatic long-term Campylobacter jejuni-infected mice
|
| 369. | | | Sustained TL1A (TNFSF15) expression on both lymphoid and myeloid cells leads to mild spontaneous intestinal inflammation and fibrosis
|
| 370. | | | Synergistic Antimicrobial Effects of Cefabronchin
|
| 371. | | | The synthetic hydroxyproline-containing collagen analogue (Gly-Pro-Hyp)10 ameliorates acute DSS colitis
|
| 372. | | | The synthetic hydroxyproline-containing collagen analogue (Gly-Pro-Hyp)10 promotes enzymatic activity of matrixmetalloproteinase-2 in vitro
|
| 373. | | | Taking stock of infections and antibiotic resistance in the elderly and long-term care facilities: A survey of existingand upcoming challenges
|
| 374. | | | Targeting antigens to DEC-205 on dendritic cells induces immune protection in experimental colitis in mice
|
| 375. | | | Tattoos causing local and even generalized lymphadenopathies including sarcoidosis
|
| 376. | | | TFF Peptides Play a Role in the Immune Response Following Oral Infection of Mice with Toxoplasma gondii
|
| 377. | | | Therapeutic effects of oral benzoic acid application during acute murine campylobacteriosis
|
| 378. | | | Tim-3 is differently expressed in genetically susceptible C57BL/6 and resistant BALB/c mice during oral infection with Toxoplasma gondii
|
| 379. | | | Tissue-specific induction of CCR6 and Nrp1 during early CD4+ T cell differentiation
|
| 380. | | | Toll-like receptor-4 dependent inflammatory responses following intestinal colonization of secondary abiotic IL10-deficient mice with multidrug-resistant Pseudomonas aeruginosa
|
| 381. | | | Toll-like receptor-4 dependent intestinal gene expression during Arcobacter butzleri infection of gnotobiotic IL-10 deficient mice
|
| 382. | | | Toll-like receptor-4 dependent small intestinal immune responses following murine Arcobacter butzleri infection
|
| 383. | | | Toll-like receptor-4 is essential for Arcobacter butzleri-induced colonic and systemic immune responses in gnotobiotic IL-10-/- mice
|
| 384. | | | Topical microemulsion with phenolic compounds from Libidibia ferrea (Fabaceae): An alternative treatment for cutaneous leishmaniasis
|
| 385. | | | Toxoplasma gondii exposure and neurological disorders: An age- and gender-matched case-control pilot study
|
| 386. | | | Toxoplasma Gondii Infection and a History of Surgery: A Case Control Seroprevalence Study
|
| 387. | | | Toxoplasma Gondii Infection and Depression: A Case-Control Seroprevalence Study
|
| 388. | | | Toxoplasma gondii infection and multiple sclerosis: An age- and a gender-matched case-control seroprevalence study
|
| 389. | | | Toxoplasma gondii infection of chicken embryos causes retinal changes and modulates HSP90B1 gene expression: A promising ocular toxoplasmosis model
|
| 390. | | | Toxoplasma gondii infection of the central nervous system and suicide: A case-control study of decedents
|
| 391. | | | Toxoplasma gondii seroprevalence and risk factors of cats in the Budapest area
|
| 392. | | | Tracheoesophageal fistula due to Candida and Actinomyces co-infection: A case report and comprehensive review of the literature
|
| 393. | | | Treatment with interleukin-18 binding protein ameliorates Toxoplasma gondii-induced small intestinal pathology that is induced by bone marrow cell-derived interleukin-18
|
| 394. | | | Trichomonas vaginalis Detection in Female Specimens with cobasW TV/MG for use on the cobasW 6800/8800 Systems
|
| 395. | | | True facets of TB diagnosis in 2012: Hypes and realities
|
| 396. | | | Tuberculosis challenges: Resistance, co-infection, diagnosis, and treatment
|
| 397. | | | Tuberculosis in adolescents and young patients in high prevalence region
|
| 398. | | | Tuberculosis surveillance and control in Germany : an application of the Berlin Declaration Monitoring and Evaluation Framework
|
| 399. | | | Usage of murine T-cell hybridoma cells as responder cells reveals interference of Helicobacter pylori with human dendritic cell-mediated antigen presentation
|
| 400. | | | Validation of the Cepheid Xpert(R) Xpress SARS-CoV-2 using upper and lower respiratory tract specimens
|
